Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Doxorubicin recalled?

Not under an active recall. Doxorubicin was recalled 8 times in the past — all now closed. Most recent: Aug 24, 2023.

Most common reason: Sterility / contamination (4 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Doxorubicin. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Doxorubicin recalls on record

none so far in 2026; 8 on record, newest first
Class III · Low risk

DOXOrubicin Hydrochloride Injection

Correct Labeled Product Mispack: Ifosfamide Injection 50 mg/mL, 60 mL, correctly labeled vial may have been mis-packaged in a carton labeled Doxorubicin Hydrochloride Injection 2 mg/mL, 100 mL

Terminated Labeling / mix-up Mylan Institutional LLC NDC 53150-317-01 D-0412-2015
Class II · Moderate risk

Doxorubicin HCI active pharmaceutical ingredient packaged in…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-640-2015
Class II · Moderate risk

Doxorubicin HCL

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

Terminated Sterility / contamination Franck's Lab Inc., d.b.a. Franck's Compounding Lab D-1509-2012